Ramya Teja Medarametla, Venkata Gopaiah K, N Suresh Kumar J, Kumar Sai A, Mohana chari G, Kranti Kiran A, Koteswarao Naik B, Sandya rani K
{"title":"A comprehensive study on the review of virosomes As a novel drug delivery system","authors":"Ramya Teja Medarametla, Venkata Gopaiah K, N Suresh Kumar J, Kumar Sai A, Mohana chari G, Kranti Kiran A, Koteswarao Naik B, Sandya rani K","doi":"10.37022/jpmhs.v6i4.94","DOIUrl":null,"url":null,"abstract":"Virosomes can be used as vaccines and vehicles for the cellular transport of various macromolecular molecules. The potential for drug delivery and targeting systems to be implemented using virosomes represents an exciting area of research. Virosomes are biocompatible, biodegradable, nontoxic, and nonimmunogenic, so efforts have been made to utilize them as anti-inflammatory or adjuvant agents, as well as drug and organic delivery frameworks for therapeutic applications. The success of virosomal drug delivery depends on the strategy used to assemble and fuse typeable bioactive materials into virosomes. Potential innovations of virosomes could be used to transport peptides and nucleic acids or qualities and drugs such as antitoxins, anticancer agents, and steroids.","PeriodicalId":493504,"journal":{"name":"UPI journal of pharmaceutical, medical and health sciences","volume":"151 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"UPI journal of pharmaceutical, medical and health sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37022/jpmhs.v6i4.94","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Virosomes can be used as vaccines and vehicles for the cellular transport of various macromolecular molecules. The potential for drug delivery and targeting systems to be implemented using virosomes represents an exciting area of research. Virosomes are biocompatible, biodegradable, nontoxic, and nonimmunogenic, so efforts have been made to utilize them as anti-inflammatory or adjuvant agents, as well as drug and organic delivery frameworks for therapeutic applications. The success of virosomal drug delivery depends on the strategy used to assemble and fuse typeable bioactive materials into virosomes. Potential innovations of virosomes could be used to transport peptides and nucleic acids or qualities and drugs such as antitoxins, anticancer agents, and steroids.